Tumor Markers in Medicine and Prevention
Tumor markers are substances in blood and urine. This can mean cancer. But even in people who are not affected by cancer, the tumor can increase. For example, during pregnancy, in smokers, in patients with cirrhosis or kidney diseases, different types of tumor markers can also indicate different organ diseases. Unfortunately, all cancers do not produce tumors that are in blood or urine, so all cancers exhibit tumor marker tests.
Tumor markers have been designed initially and during the treatment of cancer. From here you can see how it works and develops. Tumor markers can also be used to determine whether they are resistant to cancer after treatment. Constant monitoring of tumor markers is necessary in the context of chemistry or radiotherapy and is performed regularly.
Different tumor symptoms indicate disease of different organs. This allows the doctor to recognize the disease and confirm or reject cancer that is suspected by targeted research. The higher the blood concentration in the tumor, the more likely the tumor is.
As a test, tumor marker research is not included because all cancers are not associated with an increased tumor marker. This will result in false security. On the other hand, the values can also be increased for other reasons and as a result of the psychological burden of the patient increases.
For more Medical Research Analysis Get in Touch With (https://essaywriting-uk.co.uk/ )
The following tumor symptoms indicate different types of cancer:
CEA: Cancer of the colon, stomach, lung, pancreas, esophagus, thyroid and breast cancer. This level can also be used for other diseases. Without liver or pancreatic cancer, the need for follow-up research requires further training. Even smokers claim that this value is often increased.
CA15-3: A cancer protein molecule for breast and ovarian carcinoma. Despite increased tumors, hepatitis, liver cirrhosis, pancreatitis and gastrointestinal disorders or lung disease are not increased.
CA125: As mentioned above, the tumor is a sugar protein molecule that is important for the detection of ovarian cancer. However, these benign diseases can increase: bladder inflammation, pancreatitis or other gynecological diseases such as inflammation.
CA19-9: Is a sugar-containing solution that is mainly observed in pancreatic, gastric or colon and rectal tumors.
CA 72-4: Refers to ovarian cancer or stomach cancer.
PSA: When the level of PSA increases, it can be prostate cancer.
NSE and CYFRA 21-1: Values are observed when the patient has lung cancer.
If the SCC is increased, other problems may indicate that cancer may be: cervix, esophagus, and lung.
After surgical removal or radiotherapy, the tumor marker should be regularly plated to see if the tumor can be removed. For this purpose, it is necessary to establish a tumor marker before the start of treatment to gradually reduce tumor markers therapy. If the value does not decrease, we can assume that the tumor has not been completely removed. Even after treatment, the values are checked regularly to detect new cases of cancer.
The costs of research on tumor markers are:
Men need whole blood tubes to study gastrointestinal, pancreatic and prostate cancer from € 54
For women (ovarian cancer, gastrointestinal tract, and pancreas and breast cancer) about € 60 also requires thoroughbred.
Managing the risk of uterine cancer costs about € 40, -
If the patient's findings are positive D and if tumor markers are detected, further testing is needed to determine what a malignant tumor and a tumor is?